BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:W. Europe Standard Time BEGIN:STANDARD DTSTART:16011028T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10 TZOFFSETFROM:+0200 TZOFFSETTO:+0100 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010325T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3 TZOFFSETFROM:+0100 TZOFFSETTO:+0200 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20211222T095526Z DESCRIPTION:Time: 15-16h CET (3-4PM)\n11.01.2022 | ‘Anti-spastic therapie s in Hereditary Spastic Paraplegia’ by Marcondes C. França Jr.\, School of Medical Sciences\, University Campinas (UNICAMP)\, Brasil. \n\n\n25.01 .2022 | ‘ASO RNA splice modulating therapies for genetic brain disorders ’ by W.M.C. van Roon-Mom\, University of Leiden\, the Netherlands. \n\n\ n01.02.2022 | ‘Learning by example: HD-JUNIOR a national registry for pa tients with juvenile onset Huntington's Disease’ by Hannah Bakels\, Leid en University Medical Center\, the Netherlands. \n \n08.02.2022 | ‘The o verlap between the spectrum of frontotemporal dementias and atypical Parki nsonism’ by Vasilios Constantinides\, National and Kapodistrian Universi ty of Athens\, Greece. \n \n15.02.2022 | ’New MDS criteria for clinical diagnosis of MSA' by Gregor Wenning and Iva Stankovic\, Medical University Innsbruck\; Institute of Neurology\, University of Belgrade\, Serbia. \n \n08.03.2022 | ‘Brain Development in Huntington’s Disease’ by Peggy Nopoulos\, Carver College of Medicine\, University of Iowa\, USA.\n\n15.03 .2022 | ’Measuring disease severity in chronic progressive myelopathy’ by Marc Engelen\, Amsterdam University Medical Center\, the Netherlands. SIGN UP here \n \n29.03.2022 | ’Antisense oligonucleotide media ted exon skipping therapy development for Duchenne muscular dystrophy take s more than an oligonucleotide' by Annemieke Aartsma-Rus\, Leiden Universi ty Medical Center\, the Netherlands. \n\n\n05.04.2022 | ‘The logopenic v ariant of primary progressive aphasia (lvPPA): language\, cognitive\, neur oradiological issues'​ by Robert Rusina and Zsolt Cséfalvay Department of Neurology at the Thomayer University Hospital Videnska in Czech Republi c\; Department of Communication Disorders at the Comenius University in Br atislava\, Slovakia. \n \n12.04.2022 | ‘Basal ganglia diseases in childh ood'​ by Belén Perez Dueñas\, Pediatric Neurology at Vall d'Hebron Uni versity Hospital\; Vall d'Hebron Research Institute\, Barcelona\, Spain. \ n \n24.05.2022 | ‘Mitochondrial leukodystrophies’ by Anna Ardissone\, IRCCS Foundation Neurological Institute "Carlo Besta"\, Milan\, Italy. \n \n21.06.2022 | ‘Biofluid biomarkers in atypical parkinsonism'​ by Per Svenningsson\, Karolinska Institute\, Department of Clinical Neuroscience\ , Stockholm\, Sweden. \n \n12.07.2022 | ‘Importance of autopsies in leuk odystrophies’​ by Marianna Bugiani\, Amsterdam University Medical Cent er\, the Netherlands.\n \n13.09.2022 | ‘Vanishing white matter’ by Mar jo van der Knaap\, Amsterdam University Medical Center\, the Netherlands.\ n \n20.09.2022 | ’Multiple system atrophy: translational research approa ches’ by Nadia Stefanova\, Medical University Innsbruck\, Austria. \n \n 27.09.2022 | ‘Clinical and genetic predictors of subthalamic nucleus dee p brain stimulation in Parkinson’s disease’ by Daniel Weiß\, Hertie Institute for Clinical Brain Research\, University of Tübingen\, Germany. \n \n \n DTEND;TZID="W. Europe Standard Time":20220111T160000 DTSTAMP:20211222T095526Z DTSTART;TZID="W. Europe Standard Time":20220111T150000 EXDATE;TZID="W. Europe Standard Time":20220118T150000,20220222T150000,20220 301T150000,20220322T150000,20220419T150000,20220426T150000,20220503T150000 ,20220510T150000,20220517T150000,20220531T150000,20220607T150000,20220614T 150000,20220628T150000,20220705T150000,20220719T150000,20220726T150000,202 20802T150000,20220809T150000,20220816T150000,20220823T150000,20220830T1500 00,20220906T150000 LAST-MODIFIED:20211222T095526Z PRIORITY:5 RRULE:FREQ=WEEKLY;COUNT=38;BYDAY=TU SEQUENCE:0 SUMMARY;LANGUAGE=de:ERN-RND Webinar TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E008000000005053C97D1CF7D701000000000000000 010000000A6F0D87C51698F4A96487AB197104589 X-ALT-DESC;FMTTYPE=text/html: